SCHEMBL2632813

SCHEMBL2632813

CCN1CCc2cc(NC(C)=O)ccc21

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MAPT P10636 3/20 0.52
TP53 P04637 3/20 0.52
GAA P10253 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALOX5 P09917 3/20 0.47
EPHX2 P34913 2/20 0.47
KCNT1 Q5JUK3 1/20 0.47
HSP90AA1 P07900 1/20 0.46
TLR9 Q9NR96 1/20 0.46
BAZ2B Q9UIF8 1/20 0.46
POLB P06746 1/20 0.46
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13537499 0.82 NOTUM (0.44) MAPTTP53NPC1RAB9ASMN1; SMN2
SCHEMBL29119447 0.81 HSP90AA1 (0.48) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL31577274 0.81 ALOX5 (0.72) ALOX5EPHX2KCNT1
SCHEMBL2625806 0.81 NPC1 (0.61) ALDH1A1MAPTTP53GAAMEN1
SCHEMBL11813937 0.81 RAB9A (0.53) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL12381933 0.81 ALDH1A1 (0.50) ALDH1A1MAPTTP53GAAMEN1
SCHEMBL15601456 0.80 ALOX5 (0.56) MEN1KMT2ANPC1RAB9AALOX5
SCHEMBL15524920 0.80 ALOX5 (0.70) ALDH1A1ALOX5EPHX2KCNT1
SCHEMBL11682254 0.79 SMN1; SMN2 (0.70) ALDH1A1MAPTTP53NPC1RAB9A
SCHEMBL15524919 0.79 ALOX5 (0.58) ALDH1A1MEN1KMT2AALOX5EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163720-B2 Pyrrolidinyl phenyl sulphonamides as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-24 US disclosed
EP-2308872-A1 Heterocyclic derivatives as modulators of ion channels Vertex Pharmaceuticals Incorporated (US) 2011-04-13 EP disclosed
WO-2007075895-A2 HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-07-05 WO disclosed